Valeant in talks to hire Perrigo's Papa as CEO: source

Papa News Positive for Valeant (VRX) - BMO Capital

BMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) amid news Perrigo's CEO, Joseph Papa, is in discussions to become the company's next CEO.

Arfaei said, if true, this would be viewed favorably for VRX "as it removes another uncertainty... More

If Papa Leaves Perrigo (PRGO) for Valeant (VRX), It Would Be A Shocker - Jefferies

Jefferies analyst, David Steinberg, weighed in on the specialty pharma shocking news that Joe Papa may leave Perrigo (NYSE: PRGO) for Valeant Pharma (NYSE: VRX). In short, the analyst thinks it makes sense for VRX but leaves a very dark cloud over PRGO. No change to ratings or PT.

During a contentious, lengthy hostile takeover battle, CEO Joe Papa assured investors that PRGO would be much better off as an independent... More

Papa News Suggests Things are Better at Valeant (VRX) Than the Street Thinks - Guggenheim

Guggenheim analyst Louise Chen said news that Perrigo CEO Joe Papa may be leaving for Valeant Pharma (NYSE: VRX) would signal things are better than Street is thinking. Chen notes Papa was not on the list of candidates debated by the Street so this comes as a positive surprise for... More

Joe Papa News Negative for Perrigo (PRGO), But Would Back the Truck Up Under $100 - Guggenheim

Guggenheim analyst Louise Chen notes news that Perrigo Co. (NYSE: PRGO) CEO Joe Papa may be leaving for Valeant Pharma (NYSE: VRX) is a negative for Perrigo as it raise concerns about growth prospects for base business. That said they would back up the truck on PRGO's stock if its trades below $100.

"As it relates to PRGO, we think this will be... More

Joe Papa News a 'Big Surprise' - RBC Capital (VRX) (PRGO)

RBC Capital analyst, Randall Stanicky, noted that the WSJ reported that Valeant (NYSE: VRX) is finalizing a contract to name Perrigo Co. (NYSE: PRGO) CEO Joe Papa as its new CEO. Based on the number of incoming calls, and the analyst's view that perceived leadership uncertainty at this time will be viewed negatively, he felt the need to address questions we have received and offer our view. No change to the Sector Perform rating for $140 PT on PRGO.

(i) Is this a surprise? Yes a... More

Valeant Pharma (VRX) Near Deal to Name Perrigo's Joseph Papa as New CEO - WSJ

Valeant Pharma (NYSE: VRX) is close to naming Perrigo (NYSE: PRGO) CEO, Joseph Papa, as its new CEO, the Wall Street Journal reported late Thursday.

Valeant was aiming to make the announcement as soon as... More